As of 2026-07-11, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 7.79 USD. This relative valuation is based on P/E multiples. With the latest stock price at 91.88 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -91.5%.
The range of the Relative Valuation is 5.20 - 10.80 USD.
| Range | Selected | |
| Trailing P/E multiples | 11.8x - 14.1x | 13.2x |
| Forward P/E multiples | 14.1x - 18.9x | 17.0x |
| Fair Price | 5.20 - 10.80 | 7.79 |
| Upside | -94.3% - -88.2% | -91.5% |
| Date | P/E |
| 2026-07-10 | 208.33 |
| 2026-07-09 | 211.44 |
| 2026-07-08 | 210.74 |
| 2026-07-07 | 213.23 |
| 2026-07-06 | 207.72 |
| 2026-07-02 | 204.55 |
| 2026-07-01 | 200.62 |
| 2026-06-30 | 197.15 |
| 2026-06-29 | 199.29 |
| 2026-06-26 | 197.99 |
| 2026-06-25 | 192.17 |
| 2026-06-24 | 184.93 |
| 2026-06-23 | 181.06 |
| 2026-06-22 | 180.74 |
| 2026-06-18 | 181.19 |
| 2026-06-17 | 185.36 |
| 2026-06-16 | 189.81 |
| 2026-06-15 | 188.47 |
| 2026-06-12 | 187.99 |
| 2026-06-11 | 188.76 |
| 2026-06-10 | 177.13 |
| 2026-06-09 | 175.70 |
| 2026-06-08 | 166.27 |
| 2026-06-05 | 164.66 |
| 2026-06-04 | 169.81 |
| 2026-06-03 | 164.73 |
| 2026-06-02 | 161.44 |
| 2026-06-01 | 159.72 |
| 2026-05-29 | 157.56 |
| 2026-05-28 | 155.05 |
| 2026-05-27 | 151.13 |
| 2026-05-26 | 136.86 |
| 2026-05-22 | 136.55 |
| 2026-05-21 | 135.34 |
| 2026-05-20 | 133.92 |
| 2026-05-19 | 132.01 |
| 2026-05-18 | 124.98 |
| 2026-05-15 | 127.82 |
| 2026-05-14 | 132.19 |
| 2026-05-13 | 129.43 |
| 2026-05-12 | 116.00 |
| 2026-05-11 | 116.09 |
| 2026-05-08 | 118.54 |
| 2026-05-07 | 115.75 |
| 2026-05-06 | 118.25 |
| 2026-05-05 | 116.39 |
| 2026-05-04 | 117.00 |
| 2026-05-01 | 116.59 |
| 2026-04-30 | 105.48 |
| 2026-04-29 | 105.64 |